Eiken Chemical Co., Ltd. (TYO:4549)
2,170.00
-3.00 (-0.14%)
Aug 6, 2026, 11:30 AM JST
Eiken Chemical Revenue
Eiken Chemical had revenue of 10.73B JPY in the quarter ending June 30, 2026, with 5.21% growth. This brings the company's revenue in the last twelve months to 42.43B, up 2.94% year-over-year. In the fiscal year ending March 31, 2026, Eiken Chemical had annual revenue of 41.90B with 3.35% growth.
Revenue (ttm)
42.43B
Revenue Growth
+2.94%
P/S Ratio
1.69
Revenue / Employee
60.96M
Employees
696
Market Cap
71.63B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 41.90B | 1.36B | 3.35% |
| Mar 31, 2025 | 40.54B | 487.00M | 1.22% |
| Mar 31, 2024 | 40.05B | -3.22B | -7.44% |
| Mar 31, 2023 | 43.27B | 275.00M | 0.64% |
| Mar 31, 2022 | 43.00B | 4.33B | 11.20% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PHC Holdings | 364.40B |
| Nihon Kohden | 235.10B |
| Fukuda Denshi | 140.31B |
| Japan Lifeline | 60.48B |
| DVx Inc. | 55.99B |
| Seikagaku | 36.65B |
| Japan Medical Dynamic Marketing, INC. | 23.32B |
| Techno Medica | 11.24B |